Page 47 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 47

Page 18 of 26  Guideline


              52. Hesketh  PJ.  Chemotherapy-induced  nausea  and  vomiting.  N  Engl  J  Med.   67. Yarchoan R, Uldrick TS. HIV-associated cancers and related diseases. N Eng J Med.
                2008;358:2482–2494. https://doi.org/10.1056/NEJMra0706547  2018;378:1029–1041. https://doi.org/10.1056/NEJMra1615896
              53.  Nakagawa S, Toya Y, Okamoto Y, et al. Can anti-infective drugs improve the infection-  68. Bruyand M, Thiebaut R, Lawson-Ayayi S, et al., for the Groupe d’Epidemiologie
                related symptoms of patients with cancer during the terminal stages of their lives?   Clinique du Sida en Aquitaine (GECSA). Role of uncontrolled HIV RNA level and
                J Palliat Med. 2010;13:535–540. https://doi.org/10.1089/jpm.2009.0336  immunodeficiency  in  the  occurrence  of  malignancy  in  HIV-infected  patients
              54. Eggers C, Arendt G, Hahn K, et al., for the German Association of Neuro-AIDS und   during the combination antiretroviral therapy era: Agence Nationale de Recherche
                                                                      sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis. 2009;49(7):1109–1116.
                Neuro-Infectiology  (DGNANI).  HIVC-1-associated  neurocognitive  disorder:   https://doi.org/10.1086/605594
                Epidemiology, pathogenesis, diagnosis and treatment. J Neurol. 2017;264:1715–
                1727. https://doi.org/10.1007/s00415-017-8503-2     69. Bonnet F, Balestre E, Thiebaut R, et al. for the Groupe d’Epidemiologie Clinique du
              55. Eden  A, Fuchs  D, Hagberg  L,  et al.  HIV-1 viral  escape  in  cerebrospinal  fluid  of   SIDA en Aquitaine. Factors associated with the occurrence of AIDS-related non-
                                                                      Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine
                subjects on suppressive antiretroviral treatment. J Infect Dis. 2010;202(12):1819–  Cohort, France. Clin Infect Dis. 2006;42:411–417. https://doi.org/10.1086/499054
                1825. https://doi.org/10.1086/657342
              56. Goldberg DW, Tenforde MW, Mitchell HK, Jarvis JN. Neurological sequelae of adult   70. Torres HA, Mulanovich V. Management of HIV infection in patients with cancer
                                                                      receiving  chemotherapy.  Clin  Infect  Dis.  2014;59(1):106–114.  https://doi.
                meningitis  in  Africa:  A  systematic  literature  review.  Open  Forum  Infect  Dis.   org/10.1093/cid/ciu174
                2017;5(1):ofx246. https://doi.org/10.1093/ofid/ofx246
              57. Siddiqi  OK,  Ghebremichael  M,  Dang  X,  et  al.  Molecular  diagnosis  of  central   71. Bateganya  MH,  Stanaway  J,  Bretlinger  PE,  et  al.  Predictors  of  survival  after  a
                                                                      diagnosis  of  non-Hodgkin  lymphoma  in  a  resource-limited  setting.  J  Acquir
                nervous  system  opportunistic  infections  in  HIV-infected  Zambian  adults.  Clin   Immune  Defic  Syndr.  2011;56(4):312–319.  https://doi.org/10.1097/QAI.0b013e
                Infect Dis. 2014;58(12):1771–1777. https://doi.org/10.1093/cid/ciu191  31820c011a
              58. Britz E, Perovic O, Von Moolendorf C, et al. The epidemiology of meningitis among   72. Cyr C, Arboleda MF, Kumar S, et al. Cannabis in palliative care: Current challenges
                adults in a South African Province with a high HIV prevalence, 2009–2012. PLoS   and practical recommendations. Ann Palliat Med. 2018;7(4):463–477. https://doi.
                One. 2016;11(9):e0163036. https://doi.org/10.1371/journal.pone.0163036  org/10.21037/apm.2018.06.04
              59. Molloy  SF,  Kanyama  C,  Heyderman  RS,  et  al.,  for  the  ACTA  trial  Study  Team.   73. Bar-Lev Schleider L, Mecholam R, Lederman V, et al. Prospective analysis of safety
                Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl   and efficacy of medical cannabis in large unselected population of patients with
                J Med. 2018;378:1004–1017. https://doi.org/10.1056/NEJMoa1710922  cancer.  Eur  J  Intern  Med.  2018;49:37–43.  https://doi.org/10.1016/j.ejim.2018.
              60.  Kingham TP, Alatise OI, Vanderpuye V, et al. Treatment of cancer in sub-Saharan Africa.   01.023
                Lancet Oncol. 2013;14:e158–e167. https://doi.org/10.1016/S1470-2045(12)70472-2  74. Manuzak JA, Gott TM, Kirkwood JS, et al. Heavy cannabis use associated with
              61. Livingston  J.  Cancer  in  the  shadow  of  the  AIDS  epidemic  in  Southern  Africa.   reduction in activated and inflammatory immune cell frequencies in antiretroviral
                Oncologist. 2013;18:783–786. https://doi.org/10.1634/theoncologist.2013-0215  therapy-treated human immunodeficiency virus-infected individuals. Clin Infect
              62. Dryden-Peterson  S,  Medhin  H,  Kebabonye-Pusoentsi  M,  et  al.  PLoS  One.   Dis. 2018;66(12):1872–1882. https://doi.org/10.1093/cid/cix1116
                2015;10(8):e0135602. https://doi.org/10.1371/journal.pone.0135602  75. Ferry G. Thomas Browne: A rarity among rarities. Lancet. 2017;389:1687–1688.
              63. Stein L, Urban MI, O’Connell D, et al. The spectrum of human immunodeficiency   https://doi.org/10.1016/S0140-6736(17)31067-X
                virus-associated cancers in a South African black population: Results from a case-  76. Csete J, Kamarulzaman A, Kazatchkine M, et al. Public health and international
                control  study,  1995–2004.  Int  J  Cancer.  2008;122:2260–2265.  https://doi.  drug  policy.  Lancet.  2016;387:1427–1480.  https://doi.org/10.1016/S0140-
                org/10.1002/ijc.23391                                 6736(16)00619-X
              64. Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa:   77. Editor.  Progressive  interventions  needed  to  stem  medical  litigation  ‘explosion’
                Progress,  challenges,  opportunities.  Curr  Opin  HIV  AIDS.  2017;12(1):89–95.   [homepage on the Internet]. The Medical Brief. Africa’s Medical Media Digest.
                https://doi.org/10.1097/COH.0000000000000329          2018  [cited  2019  Apr  28].  Available  from:  https://www.medicalbrief.co.za/
              65. Deeken  JF,  Tjen-A-Loon  A,  Rudek  MA,  et  al.  The  rising  challenge  of  non-AIDS-  archives/progressive-interventions-needed-stem-medical-litigation.
                defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55(9):1228–1235.   78. Editor. Mpumalanga and Eastern Cape face R10.9bn in medical negligence claims
                https://doi.org/10.1093/cid/cis613                    [homepage on the Internet]. The Medical Brief. Africa’s Medical Media Digest.
              66. Coleman MP. Cancer survival: Global surveillance will stimulate health policy and   2015  [2015  Jun  13].  Available  from:  https://www.medicalbrief.co.za/archives/
                                                                      mpumalanga-eastern-cape-face-r10-9bn-medical-negligence-claims.
                improve  equity.  Lancet.  2014;383:564–573.  https://doi.org/10.1016/S0140-
                6736(13)62225-4                                     79. Shaner DM. Suspending ethical medical practice. N Engl J Med. 2010;363:1988.

                                                                                                 Appendices starts on the next page →





































                                           http://www.sajhivmed.org.za  40  Open Access
   42   43   44   45   46   47   48   49   50   51   52